Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System

Sponsor
Surgalign Spine Technologies (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT02074761
Collaborator
(none)
250
22
69.8
11.4
0.2

Study Details

Study Description

Brief Summary

Sacroiliac joint pain reduction and radiographic evidence of SIJ fusion will be collected to evaluate clinical performance of the SImmetry Sacroiliac Joint Fusion System.

Condition or Disease Intervention/Treatment Phase
  • Device: SImmetry

Detailed Description

This is a prospective, non-randomized post market study designed to evaluate fusion and pain reduction following the use of the SImmetry System. This study will be conducted at up to 40 sites and 250 total subjects will be enrolled and followed through 24 months. Data will be collected pre-operatively, implant, and at specified follow-up time points through 24 months.

Study Design

Study Type:
Observational
Actual Enrollment :
250 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System
Actual Study Start Date :
Jan 6, 2015
Actual Primary Completion Date :
Aug 1, 2019
Anticipated Study Completion Date :
Nov 1, 2020

Arms and Interventions

Arm Intervention/Treatment
SImmetry Implant

Subjects who are indicated for the SImmetry device and meet the inclusion/exclusion criteria will receive a SImmetry implant.

Device: SImmetry
The SImmetry device is commercially available. The implanted devices consist of a range of threaded, self-tapping, cannulated implants designed to transfix the sacrum and ilium, providing stability for intra-articular fusion. The SImmetry Surgical Instruments include standard manual surgical instruments used to access and prepare the sacroiliac joint space for intra-articular fusion.

Outcome Measures

Primary Outcome Measures

  1. SI Joint Fusion [12 months]

    Fusion of the SI joint at 12 and 24 months, defined as presence of a continuous segment of solid bridging bone that extends from the sacrum to the ilium. This will be assessed by an independent core laboratory

  2. SI Joint Pain Reduction [6 Months]

    SI joint pain reduction evaluated by use of Visual Analogue Scale (VAS) for back pain for comparison of baseline to 6 months.

Secondary Outcome Measures

  1. SI Joint Pain Reduction [12 months]

    SI joint pain reduction evaluated by use of Visual Analogue Scale (VAS) for back pain for comparison of baseline to all follow-up visits.

  2. Disability [6 months]

    Functional ability as determined by the Oswestry Disability Index

  3. Quality of Life [6 months]

    Quality of life as determined by EQ-5D

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Key Inclusion Criteria:
  • At least three positive provocative tests for SIJ pain

  • Non-operative management of SIJ pain for ≥ 6 months prior to surgery

  • At least one positive diagnostic SIJ injection resulting in a ≥ 50% decrease in pain

  • VAS back pain score of ≥ 60 mm

  • The subject is at least 18 years of age

Key Exclusion Criteria:
  • Trauma causing fracture of the sacrum or iliac bones or has had spinal trauma leading to a neurological deficit, or pelvic soft tissue or bony tumors

  • Pregnant or is planning on becoming pregnant in the next two years

  • Chemical dependency abuse problems as evidenced by a history of abusing drugs which is documented in their past medical history or is elicited from an interview.

  • Receiving or seeking worker's compensation, disability remuneration, and/or involved in litigation related to low back or SIJ pain

  • History of significant emotional or psychosocial disturbance

Contacts and Locations

Locations

Site City State Country Postal Code
1 The CORE Institute Phoenix Arizona United States 85023
2 BASIC Spine Newport Beach California United States 92660
3 Kaiser Permanente Oakland California United States 94611
4 Rocky Mountain Spine Clinic Lone Tree Colorado United States 80124
5 Orthopaedic Clinic of Daytona Beach Daytona Beach Florida United States 32117
6 Central Florida Neurosurgery Institute Orlando Florida United States 32801
7 Flagler Hospital Saint Augustine Florida United States 32086
8 Gainesville Physical Therapy Gainesville Georgia United States 30506
9 DK Orthopaedics Crown Point Indiana United States 46307
10 SBA Medical Center El Dorado Kansas United States 67042
11 Western Michigan University Homer Stryker MD School of Medicine Kalamazoo Michigan United States 49008
12 Tristate Brain and Spine Institute Alexandria Minnesota United States 56308
13 Essentia Health Duluth Minnesota United States 55805
14 Regional Brain and Spine Cape Girardeau Missouri United States 63701
15 Portland Pain and Spine Portland Oregon United States 97229
16 Medical University of South Carolina Charleston South Carolina United States 29425
17 Black Hills Orthopedic & Spine Center Rapid City South Dakota United States 57702
18 Azalea Orthopedics Tyler Texas United States 75701
19 University of Utah Salt Lake City Utah United States 84108
20 Bellevue Bone and Joint Physicians Bellevue Washington United States 98004
21 Fourth Corner Neurological Associates Bellingham Washington United States 98225
22 Northwest Orthopaedic Specialists Spokane Washington United States 99208

Sponsors and Collaborators

  • Surgalign Spine Technologies

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Surgalign Spine Technologies
ClinicalTrials.gov Identifier:
NCT02074761
Other Study ID Numbers:
  • CLP 007-002
First Posted:
Feb 28, 2014
Last Update Posted:
Oct 12, 2020
Last Verified:
Oct 1, 2020
Keywords provided by Surgalign Spine Technologies
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 12, 2020